MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. (Q38998812)

8 September 2017

title

MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. (English)

1 reference

8 September 2017

main subject

cervix uterine cancer

1 reference

Nan Wang

1

1 reference

8 September 2017

Yun Zhou

series ordinal

2

1 reference

8 September 2017

Lijuan Zheng

series ordinal

3

1 reference

8 September 2017

Hui Li

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

30 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

134

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

129-137

1 reference

8 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Host and viral genetics and risk of cervical cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA control of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNAs and cancer: short RNAs go a long way.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNAs: novel biomarkers for human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Patterns of known and novel small RNAs in human cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Altered MicroRNA expression in cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA-182 plays an onco-miRNA role in cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Aberrant microRNA expression in human cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Real-time quantification of microRNAs by stem-loop RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Guidelines for the welfare and use of animals in cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

ARID1A mutations in endometriosis-associated ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.047

10.1016/J.YGYNO.2014.04.047

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6xxfewazazggpgi77hq7vtnyhm

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_6xxfewazazggpgi77hq7vtnyhm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6xxfewazazggpgi77hq7vtnyhm

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/6xxfewazazggpgi77hq7vtnyhm

1 reference